Pulse Explorar nav.journalClub Debates Tendências Pesquisadores Revistas

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Início Explorar nav.journalClub Tendências

⌘+K

February 21, 2002

View Full Paper

A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance

Robert A. KyleDartmouth College TTTerry M. TherneauMayo Clinic

S. Vincent RajkumarUniversity of Maryland, Baltimore

Key Points

Key points are not available for this paper at this time.

Abstract

The risk of progression of MGUS to multiple myeloma or related disorders is about 1 percent per year.

Perguntar à IA

Like

Bookmark

Share

View Full Paper

Perguntar à IA

Like

Bookmark

Share

View Full Paper

Cite This Study

Kyle et al. (Thu,) studied this question.

synapsesocial.com/papers/69c9f1375dfe71a6b95dbdd5 https://doi.org/https://doi.org/10.1056/nejmoa01133202

A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance | Synapse

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The Analysis of Mortality by the Subject-Years Method1983 · 283 citations
2Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989 [see comments]1992 · 639 citations
3Frequency of “Abnormal” Serum Globulins (M‐Components) in the Aged1963 · 156 citations
4History of the Rochester Epidemiology Project1996 · 1,461 citations
5Estimation of failure probabilities in the presence of competing risks: new representations of old estimators1999 · 2,680 citations